SOPH
Sophia Genetics SA
NASDAQ: SOPH · HEALTHCARE · HEALTH INFORMATION SERVICES
$5.28
+5.60% today
Updated 2026-04-29
Market cap
$358.34M
P/E ratio
—
P/S ratio
4.64x
EPS (TTM)
$-1.17
Dividend yield
—
52W range
$3 – $6
Volume
0.1M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
6.7
Growth
B4.5
Quality
C2.0
Profitability
F4.7
Valuation
C2/9
Piotroski F-Score
Weak
-3.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$8.00
+51.52%
12-Month target
—
—
Intrinsic (DCF)
$4.63
Margin of safety
-3.24%
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 22.40% QoQ
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -3.43 — distress zone
- Thin margins at -102.20%
- Negative free cash flow $-9.28M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $47.56M | $62.37M | $65.17M | $77.27M | $77.27M |
| Net income | $-87.45M | $-78.98M | $-62.49M | $-79.00M | $-19.18M |
| EPS | — | — | — | — | $-1.17 |
| Free cash flow | $-80.47M | $-57.80M | $-51.00M | $-38.59M | $-9.28M |
| Profit margin | -183.87% | -126.63% | -95.89% | -102.24% | -102.20% |
Peer comparison
Smart narrative
Sophia Genetics SA trades at $5.28. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -3.43, it sits in the distress. TTM revenue stands at $77.27M. with profit margins at -102.20%. Our DCF model estimates intrinsic value at $4.63.
Frequently asked questions
What is Sophia Genetics SA's stock price?
Sophia Genetics SA (SOPH) trades at $5.28.
Is Sophia Genetics SA overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $4.63.
What is the price target of Sophia Genetics SA (SOPH)?
The analyst target price is $8.00, representing +51.5% upside from the current price of $5.28.
What is the intrinsic value of Sophia Genetics SA (SOPH)?
Based on our DCF model, intrinsic value is $4.63, a -3.2% margin of safety versus $5.28.
What is Sophia Genetics SA's revenue?
TTM revenue is $77.27M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-3.43 — distress.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.64x
ROE-110.00%
Beta1.05
50D MA$4.79
200D MA$4.37
Shares out0.07B
Float0.05B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—